Skip to main navigation Skip to search Skip to main content

Development of Novel Patient-Derived Preclinical Models from Malignant Effusions in Patients with Tyrosine Kinase Inhibitor–Resistant Clear Cell Renal Cell Carcinoma

  • Sungkyunkwan University
  • Charles River Laboratories
  • Samsung

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Development of Novel Patient-Derived Preclinical Models from Malignant Effusions in Patients with Tyrosine Kinase Inhibitor–Resistant Clear Cell Renal Cell Carcinoma'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry